CPW
REGN icon

Cove Private Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Cove Private Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Buy
910
+264
+41% +$180K 0.11% 134
2026
Q1 		$499K Buy
646
+91
+16% +$69.7K 0.11% 120
2025
Q4 		$428K Buy
555
+55
+11% +$37.4K 0.13% 117
2025
Q3 		$281K Buy
500
+40
+9% +$22.6K 0.09% 133
2025
Q2 		$242K Hold
460
– – 0.09% 142
2025
Q1 		$292K Buy
460
+20
+5% +$13.8K 0.15% 106
2024
Q4 		$313K Buy
+440
New +$369K 0.19% 88

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Cove Private Wealth's REGN Position: Q2 2026 in Review

Cove Private Wealth increased its Regeneron Pharmaceuticals (REGN) stake by 41% in Q2 2026, buying an estimated $180K and bringing the position to 910 shares worth $567K. The position accounts for 0.11% of the portfolio, ranked #134.

Cove Private Wealth first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. 504 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Cove Private Wealth held 910 shares of Regeneron Pharmaceuticals worth $567K as of Q2 2026.
  • Cove Private Wealth bought 264 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $180K.
  • Regeneron Pharmaceuticals made up 0.11% of Cove Private Wealth's portfolio in Q2 2026, its #134 holding.
  • Cove Private Wealth first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 504 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Cove Private Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.